Aveanna director files to sell up to 46K shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Aveanna Healthcare Holdings, Inc. (AVAH) director Erica G. Schwartz has filed a Rule 144 notice covering the potential sale of up to 46,071 shares of common stock on NASDAQ, with an aggregate market value of $644,994.00, based on an outstanding share count of 218,219,696 shares as of September 9, 2026.
The shares to be sold come from restricted stock granted by the issuer on February 14, 2026, July 22, 2026, and February 14, 2025. Schwartz also reports that during the prior three months she sold 230,343 shares of AVAH common stock for total proceeds of $3,224,802.00.
Key Figures
Key Terms
Rule 144 regulatory
Restricted Stock financial
aggregate market value financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does Aveanna Healthcare (AVAH) director Erica G. Schwartz plan to sell under this Form 144?
What is the recent selling history disclosed for AVAH in this Form 144?
What types of AVAH securities are being sold under this Form 144?
AI-generated analysis. How Rhea-AI works. Not financial advice.